NYAS Partners with Macy Foundation on Translational Medicine Initiative
Major funding will enable the Academy to forge a new community among basic scientific researchers and medical clinicians.
A new $454,000 grant from the Josiah Macy, Jr. Foundation will enable the Academy to establish, in partnership with the foundation, a Translational Medicine Initiative designed to forge a new community among basic scientific researchers and medical clinicians. The Academy will, in part through its new Translational Medicine Discussion Group, bring together scientists, physicians, medical students, and others focused on the challenges of translational medicine.
Meetings for combined audiences of clinicians and researchers will facilitate the translation of basic research into clinical application and improve medical school training. Specific programmatic goals include decreasing the time between discovery and clinical practice; bringing new science to the clinic by effectively integrating cutting-edge science and clinical medicine; and providing novel programming for a new cadre of physicians-in-training, including career development in translational medicine, discussion of new and improved medical school curricula, and exposure to the most recent scientific discoveries.
Academy Program Manager, Life Sciences, Sonya Dougal, says, “This initiative is an important step towards bridging the gap between basic scientists and clinical researchers. We hope that it will lead to new collaborations that will ultimately result in new treatments for devastating diseases such as Parkinson’s and Alzheimer’s disease.” The Josiah Macy, Jr. Foundation is a privately endowed philanthropy in New York City that supports programs designed to improve the education of health professionals in the interest of health of the public. For more information about the Academy’s Translational Medicine Initiative visit www.nyas.org/transmed.